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ABSTRACT 
Myocardial ischemia-reperfusion (I/R) injury is an important health concern in myocardial 
infarction and situations such as angioplasty and cardiac surgeries. Therefore, patients and 
physicians need therapeutic interventions that are applicable at the time of surgery. Flavonoids 
and ascorbate (vitamin C) are known for their antioxidant activity and may be involved in the 
currently known health benefits of plant based foods and drinks. The objectives of this study 
were to 1) determine the extent to which ascorbate or catechin alone at levels which could be in 
blood after dietary supplementation, can protect myocardial tissue in the reperfusion phase of I/R 
injury, and 2) evaluate the possible cooperative or synergistic protective effect of ascorbate and 
catechin when given together. Isolated rat hearts (n=48) were perfused in the retrograde mode 
with modified Krebs-Henseleit buffer, and following the induction of 30 min global ischemia, 
ascorbate (150 µM) and/or catechin (5 µM) were added directly into the perfusate during 90 min 
reperfusion. To determine the histopathological features, hematoxylin and eosin (H&E) stain was 
used in one heart per condition; while to assess the biochemical analysis, the heart tissues were 
assessed for apoptosis (caspase-3 activity), oxidative stress (thiobarbituric acid reactive 
substances (TBARS) and total malondialdehyde (MDA) levels), and redox status (reduced and 
oxidized glutathione tissue levels). A comparison of IR hearts with two controls, sham (perfused 
for a 15 min stabilization period) and continuous perfusion (perfused for 135 min), showed in 
most but not all measurements that this was a suitable model of IR injury. The treatment 
experiments showed that 150 µM ascorbate protected the heart against lipid peroxidation and cell 
apoptosis by 100%, while 5 µM catechin protected by 67% and 90% respectively. No 
cooperative protective effect could be observed when ascorbate and catechin were used together. 
None of the treatments significantly affected either reduced or oxidized glutathione levels. In 
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conclusion, this study showed strong protection by ascorbate, which could be used in clinically 
relevant situations, and is the first to report the protection by catechin at this dose under 
conditions of myocardial ischemia-reperfusion injury. 
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CHAPTER 1: INTRODUCTION 
  Cardiovascular diseases including coronary (ischemic) heart disease, stroke and 
hypertension are the leading cause of death worldwide. According to the World Health Report of 
the World Health Organization (WHO) 2008, cardiovascular diseases represent 30% of all global 
deaths (World Health Organization, 2010). 
 Myocardial ischemia reperfusion injury occurs in situations such as angioplasty and 
cardiac surgeries which in severe cases can increase the risk of heart morbidities. Ischemia is the 
restriction of blood flow to the heart which causes an imbalance between oxygen demand and 
supply. This imbalance eventually leads to damage of the cardiac tissues. Intuitively, early 
restoration of blood flow to the ischemic muscle would be the most effective strategy to improve 
the clinical outcome. Unfortunately, reperfusion which is restoration of blood supply to the 
ischemic myocardium can also induce injury that might be more dangerous than ischemia itself.  
 The two main causative factors of ischemia-reperfusion injury are hypothesized to be the 
accumulation of calcium in the mitochondria and the increased production of reactive oxygen 
species (ROS), which plays a major role in ischemia-reperfusion injury (Murphy et al., 2008).  
 Most of the current interventions that are being suggested to reduce myocardial ischemia-
reperfusion injury are generally effective if given before ischemia (Bolli et al., 2004). However, 
little is known about the effectiveness of treatments if applied clinically at the time of 
reperfusion to reduce the outcome of ischemia-reperfusion injury.  
 Flavonoids and ascorbate (vitamin C) which exist extensively in fruit and vegetables are 
known for their antioxidant activity and they may be involved in the currently known health 
benefits of plant foods (Arts et al., 2005).  
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 In several studies, flavonoids have shown promise in protecting against ischemia-
reperfusion injury through different mechanisms, which include antioxidation (Schewe et al., 
2008), anti-inflammatory action (Youdim et al., 2002) and vasodilation (Bell et al., 2006). 
Although all the previous studies have shown protection by flavonoids against ischemia-
reperfusion injury either in vitro or supplemented in the diet, many have used high levels and no 
studies have looked at the possible synergism of ascorbate and flavonoids against ischemia-
reperfusion injury. 
   The present study had two objectives. The first objective was to determine the extent to 
which ascorbate or catechin (a flavonoid in green tea and cocoa) alone, at dietary achievable 
concentrations, can protect myocardial tissue in the situation of ischemia-reperfusion injury. The 
second objective was to evaluate the effect of ascorbate and catechin when given together and 
the hypothesis of a possible synergistic protective effect against ischemia-reperfusion injury. 
 The study was performed in isolated rat hearts, where global ischemia was induced for 30 
min, followed by 90 minutes reperfusion. Ascorbate and catechin were added directly to the 
perfusate during the beginning of reperfusion. The heart tissues were assessed for apoptosis 
(caspase-3 activity), oxidative stress (thiobarbituric acid reactive substances (TBARS) and total 
malondialdehyde (MDA)), redox status (reduced and oxidized glutathione tissue levels) and 
histopathological features (hematoxylin and eosin (H&E) stain).  
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1. Ischemia-Reperfusion Injury (IRI) 
Ischemia is a partial or complete restriction of blood supply to an organ which results in 
tissue damage due to lack of oxygen and nutrients, while reperfusion is restoration of blood 
supply after a period of ischemia. Ischemia-reperfusion injury is one of the most serious 
complications that occur during cardiac surgeries like angioplasty, coronary bypass surgery and 
heart transplantation (Verma et al., 2002). The two main causative factors of IRI are 
hypothesized to be the accumulation of calcium in the mitochondria and the increased production 
of reactive oxygen species (ROS), which play a major role in ischemia-reperfusion injury 
(Murphy et al., 2008). On reperfusion, production of reactive oxygen species may cause effects 
such as arrhythmias, contractility dysfunction and cardiac cell death. One of the major key 
elements during this process is conversion of xanthine dehydrogenase to xanthine oxidase 
(Halestrap et al., 2006). This process, followed by mitochondrial permeability changes, results in 
more generation of reactive oxygen species and cell death (Halestrap et al., 2006) as well as 
release of pro-inflammatory cytokines (Taqueti et al., 2006). 
2.1.1. Calcium overload in IRI 
During each systole, Ca
2+ 
enters through the L-type Ca
2+
 channel, which results in Ca
2+
 
induced Ca
2+ 
release from the sarcoplasmic reticulum (SR). The Ca
2+
 that enters through the L-
type calcium channels will be removed mainly by Na
+
-Ca
2+
 exchange (NCX), with a little 
support from the sarcolemmal Ca
2+
-ATPase (Eisner et al., 2000). Studies have shown that most 
of the cytosolic Ca
2+
 rise during ischemia is mainly due to Ca
2+
 entry by reverse-mode, which 
occurs secondary to the rise in Na
+
 during ischemia (Imahashi et al., 2005). This occurs due to 
the increased generation of protons during ischemia, which are forced out from the cell via Na
+
-
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H
+
 exchange (NHE), leading to a rise in intracellular Na
+
 (Murphy et al., 1991). The increase in 
intracellular Na
+ 
will result in a reversal of (NCX) to bring more Ca
2+
 into the myocyte.
 
 
In a previous animal study, NHE inhibitors such as cariporide show reduction in the rise in 
Na
+
 and to reduce ischemia-reperfusion injury especially when administered before ischemia 
(Murphy et al. 1991). On reperfusion of myocardium, there is a sudden increase in intracellular 
Ca
2+
, which is due to the damage of sarcolemmal-membrane and oxidative stress which induces 
impairment of the sarcoplasmic reticulum function.  These two forms of injury will cause 
imbalance of the normal mechanisms that regulate Ca
2+
 in the cardiomyocyte; this phenomenon 
is called the calcium paradox (Piper et al. 1998). This will lead to an increase in the 
mitochondrial Ca
2+
 and intracellular Ca
2+
, which will induce cardiomyocyte death due to 
hypercontracture of heart cells and mitochondrial permeability transition pore (MPTP) opening 
(Piper et al., 1998) 
Hypercontracture occurs after a period of ischemia, where cardiomyocytes may react to re-
energization by developing a sudden and severe distortion of their architecture, which result from 
the excessive contractile force (Ganote et al., 1983). This hypercontacture phenomenon will lead 
to excessive cell shortening and may occur during the first few minutes of reperfusion as a result 
of adenosine triphosphate (ATP) availability in the presence of high Ca
2+
 concentration and 
cytoskeletal fragility that occurred due to ischemia (Ladilov et al., 1997). 
2.1.2. Mitochondria in IRI 
Mitochondria play a crucial role in cell survival and death (Dawson et al., 1993). The 
regulation of mitochondrial antioxidant status and the inhibition of mitochondrial permeability 
transition (MPT) pore formation can increase the protection of the myocardium to ischemia – 
reperfusion induced damage (Chiu et al., 2007). 
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The mitochondrial permeability transition (MPT) pore is a protein pore that is found in the 
mitochondrial inner membrane. It was originally discovered by Haworth and Hunter in 1979, 
where they found that induction of the permeability transition pore can lead to mitochondrial 
swelling and cell death. MPT was found to play a major role in cell damage caused by ischemia. 
However, research has shown that during ischemia, the MPT pore remains closed, but during 
reperfusion, the MPT pore opens (Bopassa et al., 2005). 
Crompton et al. (1987) were the first to discover the crucial role of MPT in cardiac 
ischemia-reperfusion injury. It was confirmed that during ischemia, MPT is inhibited by several 
mechanisms which include acidosis, increased Mg
2+
, elevated cytosolic Ca
2+
 and minimal 
reactive oxygen species (ROS) production (Fig. 2.1), while during reperfusion, after re-
oxygenation and resumption of electron transport, an excessive production of ROS is induced at 
the same time when phosphate and intracellular Ca
2+
 are increased and intracellular Mg
2+
 is 
decreased (Weiss et al., 2003). All these factors that occur during reperfusion promote MPT pore 
opening, which will result in myocardial damage during ischemia-reperfusion injury.                                                    
 
 
 
Fig 2.1. MPT and cell fate during ischemia/reperfusion. Hypothetical role of MPT in cell 
death through apoptosis during ischemia reperfusion of the heart. Pi indicates inorganic 
phosphate; ROS, reactive oxygen species (Modified from Weiss et al., 2003). 
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2.1.3. Reactive oxygen species (ROS) in IRI 
Reactive oxygen species (ROS) are a number of reactive molecules and free radicals 
derived from molecular oxygen (Zucchi et al., 2007). Due to their high reactivity, they can start 
reactions that lead to irreversible changes in lipids and proteins (Zucchi et al., 2007). During 
several physiological conditions, aerobic cells produce ROS, but due to the existence of 
endogenous scavenger systems, the cellular macromolecules are protected against reactive 
oxygen species induced injury (Hallowell et al., 1999). 
The main chemical species in ROS are superoxide radical (O2
-
), hydroxyl radical (
•
HO), 
hydrogen peroxide (H2O2) and peroxynitrate (ONOO
-
) (Halliwell et al., 1999). All aerobic cells 
contain scavenging enzymes that are able to protect against ROS. The most important enzymes 
are glutathione peroxidase, superoxide dismutase (SOD) and catalase (Mao et al., 1993). In 
several conditions, ROS generation can overwhelm the capacity of the cellular scavenging 
enzymes, which is a condition called oxidative stress (Giordano et al., 2005). Oxidative stress is 
well known for its pathophysiological role in ischemia-reperfusion injury (Dhalla et al., 2000). 
The pathophysiological role of ROS in myocardial ischemia-reperfusion has been 
suggested as a result of the increase in myocardial ROS concentration after ischemia and during 
the first few minutes of reperfusion (Kramer et al., 1987) and ROS species have also been 
recognized in the reperfused myocardium (Giordano el al., 2005). 
In the condition of myocardial ischemia-reperfusion injury, several studies have shown the 
biochemical evidence of ROS induced injury in which there was a remarkable increase in tissue 
concentrations of malondialdehyde, which confirm the evidence of occurrence of lipid 
peroxidation (Dudda et al., 1996; Tavazzi et al., 1998). 
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Mitochondria are a major source of ROS production via the respiratory chain especially 
H2O2 production, which increases remarkably during early reperfusion, possibly as a result to the 
modification in the phospholipid environment and the damage of electron transport between 
complex I and complex III (Turrens et al., 1991; Paradies et al., 2004). Furthermore, there is 
evidence that cardiomyocyte NADPH oxidases are the major source of ROS (Xiao et al., 2002; 
Soccio et al., 2005). Inhibition of electron transport at complex I and mitochondrial uncouplers 
have shown to protect against ischemia-reperfusion injury, it was proposed that this protection 
was due to the reduction of ROS production during ischemia and reperfusion (Lesnefsky et al., 
2004; Sack et al., 2006). Reactive oxygen species are also thought to be involved in the 
dysfunction of critical proteins which include the Na
+
-Ca
2+
 exchanger, cytochrome P450, 
sarcolemmal and sarcoplasmic reticulum Ca
2+
 channels (Rashar et al., 2008; Zucchi et al., 1995). 
2.2.1. Role of Ascorbic acid in IRI 
Ascorbic acid is well known for its antioxidant activity, because as a reducing agent it can 
reduce and neutralize reactive oxygen species (Padayatty et al., 2003). However, ascorbic acid 
not only behaves as an antioxidant, but sometimes also as a pro-oxidant (McGregor et al., 2006). 
Ascorbic acid has been shown to reduce transition metals, such as cupric ions (Cu
2+
) to cuprous 
(Cu
+
), and ferric ions (Fe
3+
) to ferrous (Fe
2+
) during conversion from ascorbate to 
dehydroascorbate in vitro (Satoh et al., 1997). This reaction can generate superoxide and other 
reactive oxygen species. However, in the body, free transition metal ions are unlikely to be 
present while iron and copper ions are bound to diverse proteins (McGregor et al., 2006  ) and 
the intravenous use of vitamin C does not appear to increase pro-oxidant activity under normal 
conditions (Muhlhofer et al., 2004). But in ischemia-reperfusion, metals may become 
decompartmentalized, and in these conditions ascorbic acid may act as a pro-oxidant. 
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Although previous studies on vitamin C supplementation in human cardiovascular diseases 
either alone or in combination with other antioxidants such as vitamin E did not prove great 
benefits clinically and in some cases even showed some harm (Sesso et al., 2008), vitamin C 
may still play a role in decreasing cardiovascular diseases (Bazzano et al., 2003). 
One study in an animal model of IRI found that ascorbate and glutathione are the first 
antioxidants to be depleted in heart tissues, followed by vitamin E and ubiquinone (Haramaki et 
al., 1998). However, the protective effects of ascorbate specifically to myocardial ischemia-
reperfusion injury have shown inconsistent and conflicting results. In some previous studies, 
delivery of 10-100 µM ascorbate in the perfusate after ischemia did not provide protection to 
isolated rabbit hearts against I/R injury (Holdefer et al., 1994; Rump et al., 1998); contrarily, 
detrimental effects of ascorbate have also been reported when added to rat heart perfusate (van 
Jaarsveld et al., 1994) or when delivered intravenously to rabbits (Tsovolos et al., 2008) or 
humans (Bailey et al., 2006) prior to surgical interventions involving ischemia-reperfusion. The 
detrimental effect was suggested to be mediated by iron-catalyzed oxidation of ascorbate, with 
consequent reactive oxygen species generation (Bailey et al., 2006).  
Several other studies in isolated rat hearts have shown protective effects of ascorbate. For 
example, addition of 1 or 10 mM ascorbate to the perfusate prior to global ischemia and 
reperfusion improved recovery of aortic flow (Chambers et al., 1989). Furthermore, vitamin C 
(100 µM) in the perfusate at the time of reperfusion showed protection against microvascular 
structural damage, which occurs in the reperfused myocardium (Molyneux et al., 2002). Gao et 
al. (2002) showed that the addition of vitamin C (1 mM) to the perfusate of isolated rat hearts at 
the time of reperfusion had no significant benefits alone, but it improved protection by 1 mM 
glutathione monoethyl ester.  
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In studies of oral delivery of ascorbate, several have shown protection against IR injury. In 
one study of cardiac surgeries in dogs and humans, prior and post-delivery of ascorbate orally or 
intravenously (in dogs) resulted in a decrease of post-operative fibrillations and oxidative stress 
(Carnes et al., 2001). In a clinical study of blood oxidative parameters in post myocardial 
infarction thrombolysis patients, vitamin C supplementation showed a significant increase of 
blood superoxide dismutase (SOD) activity, decrease of xanthine oxidase activity and 
tremendous decrease of malondialdehyde  (MDA) levels (Bhakuni et al., 2006). 
In a study with rats, feeding vitamin C for seven days increased vitamin C content of the 
heart and lowered some of the parameters of oxidative stress during subsequent IRI of isolated 
hearts (Sicard et al., 2006). Kearns et al., (2001) demonstrated that prior short term oral therapy 
with vitamin C attenuated reperfusion- induced injury in skeletal muscle of rats by antioxidant 
effects and an anti-inflammatory effect by attenuating neutrophil respiratory burst activity. In 
such dietary studies of vitamin C, the diet would usually also contain flavonoids, which may 
facilitate vitamin C actions. However no studies have examined a potential synergistic or 
cooperative effect of ascorbate and flavonoids in IR injury. 
A previous in vitro study (Bandy and Bechara, 2001) indicated that certain flavonoids may 
have a synergistic interaction with ascorbate that could provide potent protection to membranes 
such as those of mitochondria. Since mitochondria play an important role in ischemia-
reperfusion and cell death, this interaction may be important in protecting the heart from I/R 
injury. Flavonoids that were effective in this cooperation in vitro were quercetin and a catechin 
monomer such as epicatechin (Bandy and Bechara, 2001). 
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  2.2.2. Glutathione 
 Glutathione (GSH) is the main low-molecular-weight thiol in all aerobic cells. It is formed 
in the body from three amino acids, L-glutamic acid, glycine and L-cysteine. Glutathione or γ-
glutamyl-cysteinyl-glycine is found in cells in millimolar (0.5-10) concentrations (Lash et al., 
2006). Its effect is mainly due to the presence of the thiol group on the cysteinyl residue; where 
the thiol enables GSH to function as both a reductant and a nucleophile. Glutathione is mainly 
synthesized in the liver, most of cellular glutathione (85-90%) is found in the cytosol with the 
remainder in mitochondria and nuclear matrix (Lu et al., 2000). Glutathione plays a major role in 
many cellular reactions; the most important is scavenging free radicals and reactive oxygen 
species such as hydroxyl radical, peroxynitrite and hydrogen peroxide through enzymatic 
reactions (Fang et al., 2002). 
 Glutathione disulfide (GSSG) is the oxidized form of glutathione and intracellular 
glutathione is adequately maintained in the reduced state by glutathione reductase. On exposure 
to oxidative stress, the ratio of GSH/GSSG will be reduced due to accumulation of GSSG. 
Thereby, determination of GSH/GSSG ratio is a valuable indicator of oxidative stress 
(Akerboom et al., 1981). 
 Singh et al. (1989) reported that glutathione levels in the heart tissue following ischemia-
reperfusion could affect the intensity of myocardial damage. In a previous study, glutathione has 
reduced the post-ischemic injury in rat hearts especially after the addition of ascorbate which 
implies the possible synergism between the two hydrophilic antioxidants (Gao et al. 2002).  
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2.3. Mechanisms of flavonoid protection against IRI 
Flavonoids are a subgroup of the polyphenol family. There are more than five thousand 
flavonoids that have been identified, and they share a basic structure containing two benzene 
rings with a pyran ring in the middle (Fig 2.2) (Ross et al., 2002). Albert Szent- Györgyi (1936) 
was the first to discover flavonoids, and referred to this class of compounds as vitamin P. Dr. 
Szent-Györgyi found that vitamin C was not as effective as when vitamin P (flavonoids) was 
added to the mixture which led to improvement of the blood vessel capillaries. 
     
  
                  
Fig 2.2. Different classes of flavonoids 
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Flavonoids are known for their antioxidant activity and as they are found extensively in 
fruits and vegetables. They may be involved in the currently known health benefits of plant foods 
(Arts et al., 2005). 
In several studies, flavonoids have shown promise in preventing ischemia-reperfusion 
injury through different mechanisms, which include antioxidation through free radical 
scavenging (Schewe et al., 2008), anti-inflammation (Youdim et al., 2002) and vasodilation (Bell 
et al., 2006). Recently, it was suggested that flavonoids might affect endogenous antioxidant 
defenses of cells by modulating glutathione-related enzyme systems and glutathione (Masella et 
al., 2005).  
Although previous studies revealed that antioxidants such as vitamin C or vitamin E can 
help to partially protect against reperfusion injury in some model systems, they did not always 
have clinical success in protecting the heart from ischemia-reperfusion injury (Dhalla et al., 
2000). The different mechanisms of flavonoid protection against myocardial ischemia-
reperfusion injury were reviewed previously (Akhlaghi and Bandy, 2009) and will be highlighted 
in the following sections. 
2.3.1. Scavenging of reactive oxygen species 
Flavonoids are hypothesized to protect against myocardial ischemia-reperfusion injury by 
scavenging ROS, since they are potent scavengers of reactive species such as peroxyl radicals 
(Nakao et al., 1998), superoxide (Chun et al., 2003) and peroxynitrite (Pollard et al., 2006). In a 
previous study, after 3 weeks feeding with proanthocyanidins, there was a decrease in the 
electron spin resonance, which detects the generation of free radicals during the first few minutes 
of reperfusion (Pataki et al., 2002). Furthermore, oral treatment with quercetin for one week 
before the induction of ischemia has been shown to decrease malondialdehyde levels in heart 
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tissue, which is a marker for oxidative damage (Ikizler et al., 2007). Moreover, scavenging of 
ROS showed other benefits as a result of scavenging superoxide radicals, the bioavailability of 
nitric oxide (NO) increases (Huk et al., 1998; Freedman et al., 2001) which is expected to 
improve the endothelial function in the post-ischemic heart. 
2.3.2. Metal chelation  
It has been shown that some of the antioxidant effects of flavonoids are delivered through 
chelation of metal ions such as copper and iron (Morel et al., 1993; Maffei et al., 1996). Since 
transition metal ions are major co-factors for the Fenton reaction, their chelation by flavonoids 
can prevent their unwanted effects resulting from this kind of reaction (Gua et al., 2007; Cheng 
et al., 2000). Decompartmentalization of iron has been found to be involved in the process of 
oxidative stress in myocardial ischemia-reperfusion injury (Berenshtein et al., 1997; Horwitz et 
al., 1999), but this iron induced damage was found to be inhibited by perfusing the heart with the 
flavonoid catechin (Voogd et al., 1992). Interestingly, it has been proposed that when specific 
flavonoids bind to metals, they may act similar to superoxide dismutase, scavenging superoxide 
more potently and inhibiting the catalytic activity for the Fenton conversion of hydrogen 
peroxide to hydroxyl radicals (Kostyuk et al., 2007; Malesev et al., 2007). 
 2.3.3. Inhibition of xanthine oxidase 
   Xanthine oxidase is a form of xanthine oxidoreductase, which is an enzyme that was found 
to generate reactive oxygen species such as hydrogen peroxide and superoxide radicals (Taras et 
al., 2004). Flavonoids may inhibit xanthine oxidase, which may be one of their mechanisms in 
reducing ischemia-reperfusion injury. Several flavonoids including quercetin, apigenin and 
luteolin have shown to inhibit xanthine oxidase (Cos et al., 1998; Lin et al., 2002). In a study by 
Ashraf et al. (1993), it was verified that xanthine oxidase activity occurs in coronary vessels and 
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interstitial cells, so it possibly plays a role in ischemia-reperfusion injury. This finding led to the 
notion that inhibiting xanthine oxidase may have a protective effect against ischemia-reperfusion 
injury. 
 2.3.4. Reinforcement of cellular antioxidants 
 Antioxidants can work in a network by scavenging different reactive species and 
interacting with each other (Packer et al., 1995). For example, ascorbate can react with aqueous 
radicals such as O2
- 
while vitamin E acts in membranes where it scavenges lipid peroxyl 
radicals. Vitamin E is suggested to be regenerated from its radical at the surface of membranes 
by the effect of ascorbate, while ascorbate alternatively is regenerated by glutathione (Fig. 2.3). 
 
Fig 2.3.  Antioxidant interactions in peroxide-induced stress to mitochondria. Adapted from 
(Packer et al., 1995). 
 
 In myocardial ischemia-reperfusion injury, human studies have shown that there is a 
depletion of non-enzymatic antioxidants such as ascorbic acid and vitamin E (Marczin et al., 
2003). Interestingly, some hydrophilic antioxidants such as ascorbate and glutathione have been 
shown to be the first line of defense against oxidative stress, as they protected lipophilic 
antioxidants such as vitamin E from oxidation (Haramaki et al., 1998). In vitro, ascorbic acid is 
shown to help vitamin E regeneration from its oxidized form (Nagaoka et al., 2007).  
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 This protective network proposed that flavonoids can act as intermediate antioxidants, 
where they protect lipophilic antioxidants and at the same time are being protected by 
hydrophilic antioxidants (Lotito et al., 1999; Lotito et al., 2000). Although this seems to have 
promising results, the extent to which flavonoids may cooperate to protect other antioxidants in 
myocardial ischemia–reperfusion injury has not yet been studied. 
    2.3.5. Inhibition of metalloproteinases 
Matrix metalloprotinases (MMP) are a family of proteases, which play an important role in 
protein degradation and tissue remodeling (Spinale et al., 2007). Several studies have verified a 
direct relationship between the formation of reactive oxygen species (ROS) and the induction of 
MMP during ischemia reperfusion injury (Joffs et al., 2001; Lin et al., 2005). Additionally, in 
vitro studies have also shown that direct exposure to ROS will induce the release of MMP 
(Belkhiri et al., 1997; Cheung et al., 2000). Studies have shown that the plasma levels of MMP 
increase after ischemia reperfusion related morbidities such as myocardial infarction 
(Phatharajaree et al., 2007) and heart failure (Yan et al., 2006). Since increased activity of MMP 
is involved in ventricular dilatation and cardiac remodeling (Janicki et al., 2004), inhibitors of 
MMP may play a major protective role to prevent the complications of the ischemia reperfusion 
injury (Sang et al., 2006). 
Flavonoids have shown promising results by inhibiting the activation of metalloproteinase-
2 (Oak et al., 2005). In an earlier study, which involved human umbilical endothelial cells, 
catechin reduced the activation of metalloproteinase-2 (Oku et al., 2003). Moreover, it has been 
shown that quercetin has shown the ability to decrease the expression of metalloproteinase-9 in 
human aortic smooth muscle cells (Moon et al., 2003). 
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  2.3.6. Vasorelaxation effects  
   In addition to their antioxidant activities, flavonoids such as resveratrol and quercetin have 
also been shown to have a vasodilator effect (Chen et al., 1996), which may help in reducing 
ischemia reperfusion injury. Nitric oxide (NO) is a signaling molecule with vasodilator and anti-
inflammatory activities (Laursen et al., 2006; Reichenbach et al., 2005). Flavonoids are shown to 
increase endothelial nitric oxide synthase (eNOS) activity (Benito et al. 2002) and also induce 
eNOS expression (Olszanecki et al. 2002; Hung et al. 2004). Hotta et al. (2006) and Potenza et 
al. (2007) both tested the effect of epigallocatechin gallate in an ischemic reperfused heart and 
concluded that the induction of eNOS was part of the beneficial effect that was provided by 
epigallocatechin gallate Another mechanism by which flavonoids can produce vasodilation is by 
scavenging superoxide, which otherwise reacts rapidly with nitric oxide (producing 
peroxynitrite) and prevents its vasodilator effect. Flavonoids may also provide vasodilatation by 
stimulating endothelial cells to produce prostacyclin which is an effective vasodilator (Maffei et 
al., 1999). Oral administrations of grape seed proanthocyanidins for three weeks have been 
shown to increase the production of prostacyclin in ischemic reperfused heart (Maffei et al., 
1999). 
2.3.7. Anti-inflammatory effects 
  The effect of flavonoids on endothelial tissue and their ability to reduce inflammation 
was reported in 1936 by Szent-Györgyi and Ruszenyak. These two researchers discovered the 
effect of a substance from lemon (citrin), which improved the capillary resistance of vascular 
purpura patients (Szent-Györgyi et al., 1936). Several mechanisms that have been described have 
shown the anti-inflammatory activity of flavonoids, including anti-oxidative activities, 
modulation of cellular activities of inflammation-related cells such as macrophages, mast cells 
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and neutrophils (Middleton et al., 2000), regulation of the production of other proinflammatory 
molecules and modulation of proinflammatory gene expression. Also, certain flavonoids have 
shown the ability to modulate phospholipase A2 (PLA2) (Chang et al., 1994), lipoxygenase 
(LOX) and cyclooxygenase (COX) (Chi et al., 2001), which are metabolizing enzymes of 
arachidonic acid (AA). A suppression of these enzymes will decrease the production of crucial 
mediators of inflammation such as leukotrienes (LT) and prostaglandins (PG) (Kim et al., 2004).  
  In a previous study, catechins and quercetin have shown their inhibitory action on IL-1β 
and TNFα to improve the release of the anti-inflammatory cytokine IL-10 (Santangelo et al., 
2007). Although some studies have shown that flavonoids potentially have anti-inflammatory 
action, the effect in human subjects is still unclear. 
2.4. Previous studies on catechins in IRI 
Among flavonoids, the catechins have gained special attention as potential cardioprotective 
agents (Islam et al., 2012). Catechins are flavonoids richly present in teas and cocoa, with green 
tea being especially rich in bioavailable catechin monomers. The term catechin is commonly 
used to refer to the related family of flavonoids and the sub group flavan-3-ols (or simply 
flavanols). The name of the catechin chemical family derives from catechu, which is the juice or 
boiled extract of mimosa catechu (Acacia catechu L.F) (Zheng et al., 2008). The major catechins 
of green tea are epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin-3 gallate 
(EGCG) (Balentine et al., 1997; Dufresne et al., 2001; Higdon et al., 2003). Catechins exert 
vascular protective effects through multiple mechanisms, including antioxidant, 
antihypertensive, anti-inflammatory, anti- proliferative, anti- thrombogenic and lipid lowering 
effects (Balentine et al., 1997). 
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Catechins antioxidant activity is due to scavenging of free radicals, chelating redox active 
transition-metal ions, decreasing redox- active transcription factors, inhibiting pro-oxidant 
enzymes and inducing antioxidant enzymes (Dufresne et al., 2001). Tea catechins also decrease 
the key enzymes involved in lipid biosynthesis and reduce intestinal lipid absorption, thereby 
improving blood lipid profile (Higdon et al., 2003). Experimental and clinical studies suggest 
that tea catechins can significantly improve endothelial function, thereby providing additional 
beneficial effect in patients with CVD (Potenza et al., 2007).  
Catechins can also help in the prevention of oxidative stress-induced apoptosis (Kumar et 
al., 2002) and can inhibit p38 MAPK phosphorylation and subsequently reduce apoptosis 
(Townsend et al., 2004). Several studies have shown that reduction of P38 MAPK 
phosphorylation leads to reduction of apoptosis and improvement of cardiac function following 
myocardial ischemia-reperfusion injury (Ma et al., 1999).  
Catechins appear to be a powerful cardioprotective group of flavonoids that have shown 
promising results before or during ischemia-reperfusion in the heart, including limitation of 
infarction size and reduction of apoptosis when delivered in vitro or in vivo (Potenza et al., 2007; 
Townsend et al., 2004; Yamazaki et al., 2008; Modun et al., 2003; Aneja et al., 2004; van 
Jaarsveld et al., 1996). Furthermore, feeding green tea catechins to rats for 10 days has been 
shown to have a protective effect in isolated hearts against ischemia-reperfusion injury and 
increased the phase 2 enzyme levels (Akhlaghi and Bandy, 2010). In other studies, oral delivery 
of catechins assisted in the left ventricular function recovery after reperfusion (Yanagi et al., 
2011), and dietary catechin showed significant reduction of oxidative stress in the reperfusion 
injury, indicated by decreasing the levels of MDA (Kumar et al., 2002).  
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Previous in vitro studies on protection by catechins against IR injury have used very high 
levels of catechins (10-100 µM), and no studies have looked at the combination of a catechin and 
ascorbate in protecting from myocardial ischemia-reperfusion injury. In in vitro experiments, 
epicatechin was identified as a flavonoid which might be able to cooperate with ascorbate in 
protecting membranes and mitochondria against oxidative damage (Bandy and Bechara, 2001).  
2.5. Possible cooperation of ascorbate and flavonoids in IRI 
         In 1936, Albert Szent- Györgyi and coworkers (Bensath et al., 1936, 1937; Rusznyak and 
Szent- Györgyi, 1936) found a vitamin like principle in lime juice that they referred to as flavone 
or flavonol glucoside, which they called “citrin”. They discovered that citrin is able to treat some 
of the capillary fragility complications that occur in humans, whereas vitamin C alone did not 
produce the same effect; additionally they also found that 1mg/day of citrin could extend the life 
of vitamin C deficient guinea pigs from 28.5 to 44 days. This led to the suggestion that citrin is 
able to stabilize and potentiate the biological activity of ascorbate (Ruszenyak and Szent- 
Györgyi, 1936; Bensath et al. 1937).  Antioxidants can act in different ways; either by acting in 
the aqueous phase to react with aqueous radicals, such as with ascorbate, or acting in membranes 
to scavenge lipid peroxyl radicals, such as with vitamin E (Packer et al., 1995).  
In a previous study (Bandy and Bechara, 2001), some flavonoids were shown to transfer 
electrons from ascorbate to a hydrophobic environment and therefore they mediate antioxidant 
protection from ascorbate to membrane-bound cytochrome c in its reaction with peroxides. This 
protection is important because it has been suggested that the peroxidatic activity of cytochrome 
c may be involved in its release from the mitochondrial inner membrane in the trigger for 
apoptosis of cells undergoing oxidative stress (Davison et al., 2002; Kagan et al., 2004). These 
results suggest that during cardiac ischemia-reperfusion injury where oxidative stress occurs, a 
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combination of flavonoids and ascorbate may be synergistically beneficial in protecting against 
apoptosis. Previous studies have looked at protection against IRI by ascorbate alone or 
flavonoids alone usually at high concentrations; however no studies have looked at the possible 
synergism of different flavonoids and ascorbate in protecting from myocardial ischemia-
reperfusion injury. 
2.6. Ischemia-Reperfusion injury models 
 The two major categories of experimental myocardial ischemia-reperfusion injury in an 
isolated rat heart are global ischemia and focal ischemia. Global ischemia is when the coronary 
blood flow is reduced throughout most or all of the heart tissue, whereas, focal ischemia is 
defined as a reduction in blood flow to a specific myocardial region. In global ischemia, blood 
flow ceases completely to the whole heart while in focal ischemia there is no blood flow in the 
central core of the ischemia but there is some flow that reaches other areas via collaterals. Global 
ischemia (or no-flow ischemia) can be achieved by interrupting the coronary arteries by either 
stopping the inflow lines or partially restricting the perfusate flow rate, followed by circulation 
restoration (reperfusion). This type of ischemia might be seen during open heart surgery when 
aortic cross clamping is required, and in heart transplantation. On the other hand, focal ischemia 
can be achieved by ligating a coronary artery; the most frequently used artery is the left 
ascending coronary artery (Valentin et al., 2004; Ytrehus et al., 2000). Coronary artery ligation 
can be done in vivo during open heart surgery, or ex vivo with an isolated perfused heart. In our 
study, a global ischemia model (Langendorff heart) was used due to the simplicity of the 
preparation, low cost and the ability to test our research hypothesis clearly. 
 The Langendorff working heart was established in 1895 by the German physiologist Oskar 
Langendorff as a tool for studying heart physiology (Zimmer et al., 1998). Briefly, the main 
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principle of the technique is to keep cardiac activity by perfusing the heart through the coronary 
arteries using an aortic cannula where the ascending aorta is inserted; through this cannula, the 
perfusion solution is delivered to the heart in a retrograde manner. The retrograde perfusion 
causes the closure of the aortic valve and deviates the entire perfusate flow through the coronary 
ostia into the coronary arteries; the perfusate passes through the coronary circulation and drains 
into the right atrium via the coronary sinus and is driven out through the right ventricle. 
Although, the isolated perfused heart technique has some limitations such as the absence of the 
normal humoral effects of the heart, the high perfusion pressure of the retrograde flow in the 
aorta that may lead to incompetence of the aortic valve causing complete blockage of the entire 
perfusate through the coronary circulation and the surgical preparation of the heart which 
requires a certain degree of skills because the heart is susceptible to contusion injuries, but until 
today the technique has been actively used as a valuable method in cardiovascular research. 
However, the durations of ischemia and reperfusion vary, and most studies do not compare with 
sham and continuous-perfusion controls (Modun et al., 2003; Korkmaz et al., 2009) to establish 
the extent to which damage is due to ischemia and reperfusion versus heart isolation and ex vivo 
perfusion. This study therefore compared the IR model with both of these controls. 
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2.7. Hypothesis 
We hypothesized that vitamin C can act synergistically with catechin to protect the myocardium 
from ischemia-reperfusion injury. 
2.8. Objectives 
1. To determine the extent to which ascorbate or catechin alone, at levels which could be in 
blood after dietary supplementation, can protect myocardial tissue in the situation of 
ischemia-reperfusion injury. 
2. To evaluate the effect of vitamin C and catechin when given together and the possible 
synergistic protective effect to the rat heart against ischemia-reperfusion injury. 
3. To evaluate the strength of the IR model using sham and continuous-perfusion controls. 
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CHAPTER 3: MATERIALS AND METHODS 
 3.1 Animals and experimental groups 
        Animals were male Wistar rats weighing 200-250g. All animals were maintained and 
handled in compliance with the Canadian Council on Animal Care (CCAC) guidelines and with 
the approval of the University Committee on Animal Care and Supply (UCACS). The animals 
were assigned into six experimental groups (Fig. 3.1): 
1) Sham group (n=8). Hearts were exposed to 15 min stabilization only. 
2) Perfusion Control group (n=8). Hearts were perfused without any induction of ischemia 
for 135 min.  
3) Ischemia-reperfusion group (n=8). Hearts were exposed to 30 min global ischemia and 90 
min reperfusion. 
4) Ischemia-reperfusion plus vitamin C group (n=8). Hearts were exposed to 30 min global 
ischemia and 90 min reperfusion, with 150 µM ascorbate in the reperfusion buffer. 
5) Ischemia-reperfusion plus catechin group (n=8). Hearts were exposed to 30 min global 
ischemia and 90 min reperfusion, with 5 µM catechin in the reperfusion buffer. 
6) Ischemia-reperfusion plus vitamin C and catechin group (n=8). Hearts were exposed to 
30 min global ischemia and 90 min reperfusion, with 150 µM ascorbate and 5 µM 
catechin in the reperfusion buffer. 
 
       (+)- Catechin hydrate 98% and L-ascorbic acid 98% were obtained from Sigma-Aldrich 
Canada Ltd (Oakville, ON, Canada). L-ascorbic acid (150 µM) and catechin (5 µM) were 
prepared by dissolving the powder directly in the perfusate used for reperfusion after the 
induction of ischemia. These doses represent the maximum that might be obtained in the blood 
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with dietary supplementation, and based on the literature (Bartekova et al., 2010; Scarabelli et 
al., 2009) this dose of flavonoid alone may give mild protection. 
 
 
 
 
Figure 3.1 Consort diagram of the experiment.  
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3.2 Ischemia-reperfusion  
         The animals were anaesthetized with an initial flow of 5% isoflurane and maintenance flow 
of 3% in 1L/min of 100% oxygen. The animals were heparinized via intracardiac injection with 
350 IU/Kg heparin. Then the chest wall was fully opened and the heart was removed, the heart 
was immediately immersed in cold perfusate and cannulated through the aorta on a Langerndorff 
apparatus. The maximum time between removal of the heart and cannulation through the aorta 
was six minutes; any heart that exceeded this time period was excluded from the results.         
        The hearts were perfused in the retrograde mode with modified Krebs-Henseleit buffer 
which contained 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 25 mM NaHCO3, 1.25 mM 
CaCl2, 1.2 mM KH2PO4, and 11mM glucose, pH 7.4 (Imahashi et al., 1999). The perfusate was 
continuously bubbled with a mixture of 95% oxygen and 5% carbon dioxide. The perfusate was 
warmed to 37
0
C using a heating coil connected to a circulating water bath and the temperature of 
the heart was maintained at 37
0
C by the warm buffer in addition to a small water-jacketed 
chamber. 
 The sham group was used as a surgical control group in our experiment, which is 
commonly used in any study involving a surgical procedure to assure that the scientific data 
indicate the effects of the experiment itself and not the consequence of the surgery. The 
perfusion control group in our study was designed to keep the heart perfused for the entire time 
without any induction of ischemia.  
        All the hearts were exposed to a 15 min stabilization period before inducing ischemia. After 
the stabilization period, global ischemia was induced for 30 min by clamping the lower valve of 
the apparatus tube, and then the reperfusion was restored for 90 min by unclamping the lower 
valve rapidly. Ascorbate and catechin were added directly during the beginning of the 
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reperfusion period. At the end of reperfusion period, the hearts were snap-frozen in liquid 
nitrogen and kept at -70
0
C for later analysis. The hearts from the sham group were frozen at the 
end of the 15 min stabilization period. The hearts from the perfusion control group were perfused 
for the stabilization period and continuously for a total of 135 min; while the hearts from the 
ischemia-reperfusion and the treated groups were exposed to ischemia for 30 min after the 
stabilization period and reperfusion for 90 min. The stabilization period was 15 minutes to 
ensure that contractile function and heart rhythm return to normal. The total number of rats was 
48, but after excluding some hearts either due to the time between isolation of the heart and 
mounting the aorta exceeded 6 minutes, or due to abnormal heart rhythm after 15 minutes 
stabilization; the total number after exclusion was 39 rats as follows: sham group (n=6), control 
group (n=6), IR group (n=6), IR/ vitamin c group (n=7), IR/ catechin group (n=7), IR/ vitamin c/ 
catechin group (n=7). 
3.3 Tissue crushing 
         Frozen hearts were crushed to a powder using a tissue pulverizer which was prechilled in 
liquid nitrogen. For tissue analysis, samples of pulverized frozen tissue were weighed out and 
homogenized in the appropriate buffer using a microcentrifuge tube homogenizer. 
3.4 Caspase-3 activity 
       Caspase-3 activity was determined by incubation of tissue homogenates with a caspase-3 
substrate and colorimetric detection of the cleaved substrate due to digestion by caspase-3 in cell 
lysate (Masini et al., 2003). Briefly, 0.03 g of the frozen tissue was homogenized in 500 µl cold 
lysis buffer containing 50 mM KCl, 10 mM Hepes, 5 mM MgCl, 10 mM dithiothreitol (DTT), 
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1mM phenylmethylsulfonyl fluoride (PMSF), 2 µg/ml leupeptin, 2 µg/ml aprotinin and 0.5% 
CHAPS (3- 3-cholamidopropyl)dimethylammonio]-1- propanesulfonate), pH 7.4. The 
homogenated tissues were incubated on ice for 15 min and centrifuged at 10,000 g for 10 min at 
4°C. Then 6 µl of 10 mM caspase-3 substrate Ac-DEVD-p-nitroanilide (EMD Biosciences, San 
Diego, CA, USA) was incubated with 170 µl of the sample supernatant for 1h at 37°C, and the 
absorbance of the cleaved substrate p-nitroanilide, was measured at 405 nm. The extinction 
coefficient of 8300 M
-1
 cm
-1 
was used to determine the p-nitroanilide concentration. The activity 
was calculated as µmol of p-nitroanilide/min/mg of protein. 
3.5 Thiobarbituric acid reactive substances (TBARS) 
       Peroxidation in tissues was detected by the TBARS assay based on the reaction of 
thiobarbituric acid with reactive aldehydes present in the tissue samples, forming a colorimetric 
adduct that could be detected using spectrophotometer (Ohkawa et al. 1979). Briefly, 0.05 g of 
the frozen tissues was homogenized with 200 µl of either 3% metaphosphoric acid (MPA) or 
RIPA buffer containing 50 mM Tris, 150 mM KCl, 1% sodium deoxycholate, 1% Triton X-100, 
0.1% SDS and 0.1% EDTA, pH 7.2. The homogenates were incubated for 30 min at room 
temperature, and centrifuged at 10,000 g for 10 min at 4°C. A 100 µl aliquot of homogenized 
tissue sample supernatant was added to 400 µl of thiobarbituric acid solution containing 0.02% 
BHT, 8.1% SDS, 0.8% thiobarbituric acid, and 20% acetic acid, pH 3.5, and heated for 1h at 
95°C. The heated samples were cooled in cold water, centrifuged at 4,000 g for 10 min, and the 
absorbance of the supernatant was measured at 532 nm. The concentration of TBARS was 
calculated using a standard curve of malondialdehyde (MDA) prepared from tetraethoxypropane 
by acid hydrolysis (Esterbauer & Cheeseman, 1990). 
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3.6 Total malondialdehyde (MDA) 
 Lipid peroxidation is a well - established indicator of oxidative stress in tissues. In our 
study, we used the TBARS method to measure MDA in the samples. However, this reaction is 
non-specific to some extent; because other aldehydes and ketones can react. The MDA-586 
method was designed to assay total MDA in the tissues (Gerrard- Monnier et al., 1997). Briefly, 
0.06 g of the frozen tissue was homogenized with 300 µl diluted hydrochloric acid, pH 1.5. The 
homogenates were hydrolyzed for 80 minutes at 60°C and centrifuged at 2,000 g for 10 minutes 
at 4°C. A 100 µl aliquot of homogenized tissue sample supernatant was added to 325 µl of 15 
mM 1-methyl-2-phenylindole and 75 µl of concentrated 37% hydrochloric acid. The resulting 
samples were incubated at 45°C for 40 minutes and centrifuged for 5 minutes at 2,000 g. The 
absorbance of the supernatant was measured at 586 nm. The concentration of malondialdehyde 
(MDA) was calculated using a standard curve of malondialdehyde prepared from 1, 1, 3, 3-
tetraethoxypropane by acid hydrolysis (Esterbauer & Cheeseman, 1990). 
3.7 Histological analysis using hematoxylin and eosin stain (H&E) 
 The hematoxylin and eosin (H&E) stain is considered the routinely used stain in 
histopathology which provides a detailed view of the tissue by staining cell structures including 
nucleus, cytoplasm and organelle components. Briefly, the heart was sliced into four 2 mm 
thickness cross-sectional pieces, all the slices were fixed in 10% formalin and were embedded in 
paraffin for 48 hours. Heart samples were sliced (5 µM) in the pathology lab (City Hospital, 
Saskatoon).  The slides were assessed by a pathologist who was blinded to our experimental 
protocol. For the H&E stain, only one rat per group was used to detect if there was any 
degeneration, necrosis and edema. 
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 3.8 Glutathione measurement 
 Tissue glutathione and glutathione disulfide were determined according to a method 
described by Akerboom and Sies (1981). Briefly, 0.05 g of tissue was mixed with 300 µl meta-
phosphoric acid solution containing 3% meta-phosphoric acid. Homogenized samples were left 
on ice for 10 min and centrifuged at 10,000 g for 10 min at 4°C. For glutathione (GSH) 
measurements, 50 µl of the protein-precipitated supernatants was added to 140 µl of 50 mM 
potassium phosphate buffer, pH 8.5, mixed and the background absorbance was measured at 412 
nm. Then, 2 µl of 10 mM 5, 5'-dithiobis (2-nitrobenzoic acid) (DTNB) (in methanol) was added, 
mixed and incubated for 10 min in the dark. A second reading at 412 nm was performed and the 
difference between the two readings was used to determine the glutathione level in the tissue. 
 For glutathione disulfide (GSSG) measurement, 50 µl of the protein free supernatants was 
added to 144 µl of 50 mM potassium phosphate buffer, pH 8.5, with 4 µl of 10 mM NADPH. 
The initial absorbance was recorded at 340 nm, and 2 µl of (20 U/ml) glutathione reductase was 
added, mixed and the samples were incubated at room temperature for 40 min and read again. 
The differences of the two readings indicate NADPH consumption, and therefore the amount of 
glutathione disulfide present. Standard curves were plotted using pure glutathione disulfide and 
glutathione. The values for tissue glutathione were calculated according to the standard curves 
and weight of the tissues used. 
3.9 Statistics 
 Statistical analysis was performed with Graph Pad Prism software using one-way analysis 
of variance (ANOVA). Data shown are means ± SEM.  Comparisons were made between hearts 
in the different groups using 2-sided Tukey test as the post hoc test. A P value ˂ 0.05 was 
considered significant. 
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CHAPTER 4: RESULTS 
4.1 Glutathione and glutathione disulfide 
 Glutathione (GSH) is one of the most important endogenous antioxidants acting against 
reperfusion-induced oxidative stress, wherein it participates in the antioxidant network and may 
become oxidized. In our experiments using the isolated heart model, the level of heart GSH did 
not significantly decrease with ischemia-reperfusion compared to controls, and none of the 
treatments gave improvement of glutathione levels in the heart tissues (Fig 4.1). The level of 
glutathione disulfide (GSSG) in the hearts was also not significantly affected by ischemia-
reperfusion or by any of the treatments, although there was a trend toward an increase in the 
ischemia-reperfusion group and a suggestion of protection by the treatments (Fig. 4.2). Similar to 
GSH and GSSG, there was no significant difference between groups in the GSH to GSSG ratio 
(Fig. 4.3). 
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Figure 4.1 The level of GSH in the heart tissue was determined with DTNB as described in 
materials and methods. The bars show means + SEM. * indicates significant difference 
between Sham, control, IR and treatments groups (p < 0.05) (ANOVA, p= 0.0001; Sham 
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vs IR+Asc, p= 0.0001; Sham vs IR+Cat, p= 0.0070; Sham vs IR+Asc+Cat, p= 0.0001; 
Control vs IR+Asc, p= 0.0033; Control vs IR+Asc+Cat, p= 0.0022, IR vs IR+Asc, p= 
0.0011; IR vs IR+Asc+Cat,p= 0.0007). 
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Figure 4.2 The level of glutathione disulfide (GSSG) in the heart tissue was determined by 
oxidation of NADPH in the presence of glutathione reductase as described in materials and 
methods. The bars show means + SEM.  
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Figure 4.3 Ratio of glutathione (GSH) to glutathione disulfide (GSSG) in heart tissues.* 
indicates significantly different from Sham group (p < 0.05). (ANOVA, p= 0.0289; Sham vs 
IR+Asc+Cat, p= 0.0401). 
4.2. TBARS 
 To assess ischemia-reperfusion induced oxidative stress in cardiac cells, TBARS which is 
an indicator of oxidative stress was measured using heart tissue homogenized in RIPA buffer 
(Fig 4.4) and MPA buffer (Fig 4.5). In assays using RIPA buffer (Fig 4.4), ascorbate, catechin 
and ascorbate plus catechin gave significant inhibition of lipid peroxidation compared to IR, 
which showed  100% protection relative to sham and control groups. None of the treatments 
gave statistically improvement when MPA buffer was used to homogenize the tissue (Fig 4.5), 
although the pattern was similar to that observed in RIPA buffer. 
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Figure 4.4 Levels of TBARS in homogenates using RIPA buffer. The TBARS assay was used to 
measure reactive aldehydes in heart tissues homogenized in RIPA buffer. Bars are means + 
SEM. * indicates significantly different from IR group (p < 0.05). (ANOVA, p= 0.0004; IR+Asc 
vs IR, p= 0.0006; IR+Cat vs IR, p= 0.0403; IR+Asc+Cat vs IR, p= 0.0006). 
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Figure 4.5 Levels of TBARS in homogenates using 3% metaphosphoric acid (MPA). The 
TBARS assay was used to measure reactive aldehydes in heart tissues homogenized in 
metaphosphoric acid buffer. Bars are means + SEM.  
4.3. Total MDA 
 To assess ischemia-reperfusion induced oxidative stress in cardiac cells, total MDA 
which is an indicator of oxidative stress was measured (Fig 4.6) using the colorimetric assay for 
total MDA (Gerrard-Monnier et al., 1998). Ascorbate showed more than 100% inhibition of lipid 
peroxidation, catechin showed 67% inhibition, while ascorbate plus catechin showed 71% 
inhibition compared to ischemia-reperfusion and sham groups. 
 
 
 
34 
 
S
ha
m
C
on
tr
ol IR
IR
+A
sc
IR
+C
at
IR
+A
sc
+C
at
0
1
2
3
4
*
* *
*
*
Total MDA
T
o
ta
l 
M
D
A
(n
m
o
l/
g
 t
is
s
u
e
)
 
 Figure 4.6 Total malondialdehyde (MDA) in heart tissues. The bars represent means + SEM. * 
indicates significant difference from IR (p < 0.05). (ANOVA, p= 0.0001; Sham vs IR, p= 
0.0001; Control vs IR, p= 0.0006; IR+Asc vs IR, p= 0.0001; IR+Cat vs IR, p= 0.0021; 
IR+Asc+Cat vs IR, p= 0.0011). 
 
4.4. Caspase-3 activity 
 Apoptosis in the heart tissues was determined using examination of caspase-3 activity, 
one of the important effector caspases involved in the pathway of apoptosis. Ischemia-
reperfusion increased the activity of caspase-3 activity (Fig 4.7). Ascorbate, catechin and 
ascorbate plus catechin gave up to 100% protection against caspase-3 activation compared to the 
IR and Control groups. 
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Figure 4.7 Caspase-3 activity in heart tissues. Caspase-3 activity was measured 
colorimetrically from cleavage of the substrate Ac-DEVD-p-nitroanilide. The bars 
represent means + SEM. * indicates significant difference between IR, control and 
treatments groups (p < 0.05). (ANOVA, p= 0.0011; IR+Asc vs IR, p= 0.006; IR+Cat vs 
IR, p= 0.030; IR+Asc+Cat vs IR, p= 0.004; Control vs IR, p= 0.007). 
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4.5. Histological analysis using hematoxylin and eosin stain (H&E) 
 Light micrographs of H&E stained myocardium according to each group shows: 
                  
A) Sham heart                             B) Control heart 
 
C) IR heart 
Figure 4.8 Sham and Control groups: normal cardiac muscle fibers with centrally located nuclei 
(Fig 4.8 A and B) and IR group: myonecrosis (arrow) and edema (arrowhead) (Fig 4.8 C). 
 
In the Sham and Control groups, the heart showed normal myocardium with striated 
muscle fibers and centrally located nuclei (Figure 4.8 A and B). The IR group showed focal areas 
of degeneration and necrosis in the cardiac muscle fibers with loss of its striation (Figure 4.8 C). 
In this condition, the nuclei were pyknotic or completely absent, and the sarcoplasm became 
contracted and more eosinophilic (Figure 4.8 C).  
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For the H&E stain, only one rat per group was used, but the histopathological 
observations were graded by a blinded pathologist with regard to degeneration and necrosis in 
the cardiac muscles and edema. The pathologist grading of the histopathology in each of the 
hearts is shown in Table 1. Vitamin C treated heart showed mild degeneration, necrosis and 
edema, vitamin c plus catechin have also shown the same effect compared to the IR heart which 
showed severe degeneration, necrosis and edema. 
 
 
Table 1. Histopathological grading of hearts. *(-) nil, (+) mild, (++) moderate, (+++) severe. 
Each heart was evaluated based on 3 images. 
 
 
  
 
Groups Degeneration and necrosis                 Edema 
 
Sham 
 
                  -                   - 
Control 
 
                  -                   - 
IR 
 
               ++++                +++ 
Vitamin C 
 
                 +                  + 
Catechin 
 
                ++                 ++ 
Vitamin C & Catechin 
 
                 +                  + 
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CHAPTER 5: DISCUSSION 
  Although previous studies have looked at the protection against ischemia-reperfusion 
injury by ascorbate alone or flavonoids alone, most have used very high concentrations and no 
studies have looked at the possible cooperation of flavonoids and ascorbate in protecting from 
myocardial ischemia-reperfusion injury. We hypothesized that ascorbate can act synergistically 
with a relatively low level of catechin to protect the myocardium from ischemia-reperfusion 
injury.  
 5.1. Lipid Peroxidation 
 The results of the study herein showed that dissolving ascorbate powder directly in the 
perfusate following the induction of ischemia gave more than 100% significant protection 
against oxidative damage which occurs following ischemia-reperfusion, as assessed using 
thiobarbituric acid reactive substances (TBARS) and total malondialdehyde (MDA). Although 
TBARS is a well-established method to detect oxidative damage in tissues, it is not entirely 
specific to lipid peroxidation because other aldehydes and ketones can react. Ascorbate also gave 
100% significant protection against oxidative stress when evaluated by total MDA.  
 Similar to our results, Molyneux et al. (2002) found that 15 min reperfusion of isolated 
rat hearts with 100 µM ascorbate after 45 min of ischemia reduced the levels of malondialdehyde 
using TBARS  to levels similar to the control (a non-ischemic group perfused for the full 60 min 
time period). In addition, ascorbate supplementation to post reperfusion patients who 
experienced myocardial infarction showed complete restoration of malondialdehyde to normal 
levels (Bhakuni et al., 2006).  
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 However our result with ascorbate is in disagreement with reports that administration of 
ascorbate, delivered during reperfusion had no effect on post-ischemic injury in isolated rat heart 
(Gao et al., 2002). The reason for this disagreement is not clear, but the reperfusion period used 
by Gao el al. (2002) might be the reason, which was 120 minutes, while in our study, it was only 
90 minutes. 
  Catechin (5 µM) also decreased lipid peroxidation by 67% which was assessed by 
TBARS and total MDA. Similar to our results, Modun et al. (2003) has reported the ability of 
catechin to inhibit lipid peroxidation in heart ischemia-reperfusion with oral delivery of 250 mg 
pure catechin for 10 days prior to the induction of ischemia-reperfusion injury. In addition, Babu 
et al. (2006) have reported the protective effect of green tea extract in reducing lipid peroxidation 
in the hearts of streptozotocin induced diabetic rats following the delivery of 300 mg/kg per day 
for 4 weeks. These previous studies that tested the effect of catechin against lipid peroxidation 
have used high in vivo doses which allow accumulation in the tissues; our study shows directly 
the protection by catechin against lipid peroxidation at a level that might be achieved in blood in 
vivo, in an in vitro condition of myocardial ischemia-reperfusion. 
 Although ascorbate and catechin were effective in protecting the isolated rat heart against 
lipid peroxidation following ischemia-reperfusion injury, the complete protection provided by 
ascorbate alone did not allow observation of a synergistic effect when given together.  
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5.2. Cell apoptosis 
 In ischemia-reperfusion injury, cell death occurs by both necrosis and apoptosis (Zhao & 
Vinten-Johansen et al., 2002). In our study, caspase-3 activity was measured as an indicator of 
cell apoptosis. 
 Consistent with the results on lipid peroxidation, ascorbate inhibited the activation of 
caspase-3 significantly up to 100%, while catechin inhibited the activation of caspase-3 activity 
by 90%. Also similar to our lipid peroxidation results, ascorbate and catechin individually 
inhibited so strongly that no cooperation was observable when given together. 
  Several in vitro and ex-vivo studies have revealed the effect of catechins in limiting 
apoptosis and infarction size. Townsend et al. (2004) reported the effect of catechin after adding 
100 µM to the perfusion buffer 30 minutes before the induction of ischemia and during perfusion 
for 60 minutes, where it reduced the percentage of infarction within the risk zone. Furthermore, 
Aneja et al. (2004) have reported that administration of 10 mg/kg/iv catechins following the 
induction of 30 minutes ischemia followed by continuous infusion of 10 mg/kg/h during two 
hours reperfusion period have shown protection against cell apoptosis. 
  Other studies have shown orally administered catechins to protect against heart 
reperfusion injury. In the study by Townsend et al. (2004) oral supplementation of catechin (100 
µM in drinking water) for 7 days gave a significant decrease in caspase-3 activity in cardiac 
muscle following ex vivo ischemia-reperfusion. In another feeding study, Suzuki et al. (2007) 
reported the significant effect of catechin in reducing apoptosis and necrosis after feeding rats 20 
mg/kg/day catechin for 14 days. Yanagi et al. (2011) showed that 1mmol/L drinking water of 
epigallocatechin-3-gallate (EGCG), which is the most abundant polyphenolic catechin in green 
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tea, reduced myocardial apoptosis by inhibiting caspase-3 activation in an isolated rat heart 
model. Akhlaghi and Bandy (2010) have also confirmed the protective effect of green tea extract 
supplied in the diet for 10 days which inhibited caspase-3 activation by 85% in hearts subjected 
to ex vivo ischemia-reperfusion. 
 To date, no study has tested the dose or the route of administration that was used in our 
study. In this study, only 5 µM of catechin was used and it was added to the perfusate following 
30 min of global ischemia, while other in vitro studies have added catechin to the perfusate 
before induction of global ischemia. While adding catechin before and after ischemia might have 
stronger effect compared to adding it after the period of ischemia as we did in our study, our 
results show that the presence of a reasonably low amount of catechin in the perfusate only 
during reperfusion can give strong protection. 
  The protective effect of ascorbate in inhibiting caspase-3 activation has also been 
reported by other investigators; Ichiki et al. (2008) found that ascorbate treatment inhibited the 
activation of caspase-3 by reducing the apoptotic Kupffer cells in hepatic ischemia-reperfusion 
injury. Also, ascorbate was able to reduce caspase-3 activity during hypoxia-reperfusion in 
human endothelial cells (Dhar et al., 2005). To our knowledge, no study has tested the protective 
effect of ascorbate on apoptosis following myocardial ischemia-reperfusion injury. Our study is 
the first to report the effect of 150 µM ascorbate in reducing apoptosis (caspase-3 activity) 
following myocardial ischemia-reperfusion injury in an isolated rat heart.  
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5.3. Tissue glutathione levels 
 Despite the fact that the treatment groups had remarkably reduced oxidative damage and 
cell death, surprisingly, they did not inhibit a decline in cellular reduced glutathione (appeared to 
make it worse), nor improve the GSH to GSSG ratio, which is an important biomarker that 
reflects the cellular redox state. The level of glutathione disulfide (GSSG) in the hearts was also 
not significantly affected by ischemia-reperfusion or by any of the treatments, although there was 
a trend towards an increase with ischemia-reperfusion and a suggestion of protection by 
ascorbate and catechin. 
 The effect of ascorbate on glutathione levels in our study is in disagreement with reports 
from other investigators; Molyneux et al. (2002) has reported that ascorbate was able to keep the 
glutathione and glutathione disulfide levels similar to the control group values. The possible 
reason for this inconsistency is the reperfusion time used in Molyneux study which was 15 
minutes reperfusion only, while in our study, the reperfusion time was 90 minutes. In hepatic 
ischemia-reperfusion injury, ascorbate was also able to preserve the glutathione levels similar to 
the control and sham operated groups (Korkmaz et al., 2009), but the dose of ascorbate in this 
study was 250 mg/kg (1.4 mM) injected intra-peritoneally 1 hour prior to ischemia, whereas in 
the current study, we only used 150 µM of ascorbate added directly to the perfusate for 90 
minutes following 30 minutes of global ischemia.  
 Similar to ascorbate, catechin had no significant effects on GSH, GSSG, or GSH/GSSG 
ratio. Comparable to our results, Akhlaghi et al. (2010) has reported that feeding rat with green 
tea extract for 10 days prior to ex vivo ischemia-reperfusion had no significant effects on the 
GSH, GSSG, or GSH/GSSG ratio. Our results are in controversy with those of Yamazaki et al. 
(2008) which showed that oral gavage of 1mg/kg/day of epicatechin for 10 days prior to 
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coronary artery occlusion and 2 days during reperfusion in vivo significantly reduced the 
GSSG/GSH ratio compared to the ischemia-reperfusion control group which had a significant 
increase in GSSG/GSH ratio. An important difference when comparing our study with this study 
was that the epicatechin was delivered prior to and for 2 days continuously during the 
reperfusion period, which can influence the cellular redox state.  In our study, catechin was 
delivered only for 90 minutes during the reperfusion period. 
 In addition, longer term in vivo delivery of catechins, unlike the current acute in vitro 
situation, may influence glutathione levels through effects on glutathione biosynthesis. In 
streptozotocin induced diabetic rats for example, delivery of 300 mg/kg per day of green tea 
extract for 4 weeks improved the antioxidant status by increasing glutathione levels significantly 
in the rat hearts (Babu et al., 2006).  
 The possible explanation for the lack of catechin effect on glutathione levels in our study 
may be due to the involvement of glutathione in detoxification reactions. Oxidized catechin has 
electrophilic properties, and can be detoxified through conjugation with glutathione which may 
affect the cellular glutathione level after being oxidized in oxidative conditions such as ischemia-
reperfusion. Formation of catechin-glutathione adducts has been reported in the presence of 
peroxidase and hydrogen peroxide (Moridani et al., 2001). In addition, glutathione adducts and 
GSSG may be excreted from the myocardial cells into the perfusate effluent. 
5.4. Histological analysis  
 The hematoxylin and eosin (H&E) stain was used in this study for histological analysis, 
only one rat heart per group was stained with H&E. The H&E stain is considered the routinely 
used stain in histopathology, which provides a more detailed view of the tissue by staining cell 
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structures including the nucleus, cytoplasm and organelles components. In this study, H&E stain 
has shown normal myocardium with striated muscle fibers and centrally located nuclei in the 
sham and control group, while the IR group has shown focal areas of necrosis and degeneration 
in the cardiac muscle fibers with loss of its striation. In an independent evaluation the ascorbate 
treated rat has shown less edema and degeneration compared to IR rat. Since there was only one 
rat per group, it is difficult to conclude that ascorbate was protective.  It would be valuable to test 
ascorbate with the same dosage using H&E stain with larger sample of rats. 
5.5. Evaluation of the IR Model 
 Although the Langendorff ischemia-reperfusion model is actively used as a useful 
method in cardiovascular research (Skrzypiec-Spring et al., 2007; Bell et al., 2011), controls for 
baseline (sham) and continuous perfusion are rarely used. Such controls establish validity of the 
model and show the real strength of any protection. For example, all of the previous research that 
were done on protection by catechins or ascorbate using this model of global ischemia were 
lacking the non-ischemia continuous perfusion group (Molyneux et al., 2002; Gao et al., 2002; 
Modun et al., 2003; Townsend et al., 2004 and Korkmaz et al., 2009), to indicate the influence of 
ischemia. Some had a baseline sham group, while others had no controls except for the IR group 
without treatment (Gao et al., 2002). 
  In this study, some of the measurements did not show a significant difference between 
the non-ischemia perfusion control group and the ischemia-reperfusion group. The glutathione 
levels in heart tissues, and also the TBARS levels showed a non-significant difference between 
these groups. The reason is not clear. However, a possible explanation would be due to the time 
of ischemia which was only 30 minutes and it is possible that 30 min was not enough duration to 
cause enough insult to the rat heart. For example, a study on global ischemia-reperfusion in 
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mouse hearts (Wang et al., 2001) showed increasing damage and loss of function with ischemic 
periods up to 60 min. But the fact that both groups have shown similar results for the glutathione 
and TBARS levels raise a concern regards the reliability of the IR model. Nevertheless, the 
measurements of MDA and caspases-3 activity showed significant differences between IR and 
perfusion controls in my study, and also showed significant protection by ascorbate and catechin. 
5.6. Potential Limitations 
 One limitation was that the biochemical analyses in this study were performed on 
complete hearts and not selectively on the ischemic area. If the analyses could be performed 
more specifically on the area impacted in the IR group, larger differences could likely be 
observed. 
 Another limitation was that the experiments were conducted in healthy animals, while in 
the clinical situation, patients will likely be suffering from co-occurring diseases such as diabetes 
and hypertension. 
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1. Conclusions 
 In conclusion, this study shows that ascorbate alone (or in combination with catechin); 
under the condition of ischemia-reperfusion injury gave a strong protection against cell death and 
oxidative damage. Based on the study results, ascorbate can be used clinically for patients 
undergoing angioplasty, cardiac surgery, or heart transplantation especially since ascorbate was 
delivered directly into the perfusate during the reperfusion period. While not tested in the current 
model, ascorbate might also be used in the diet for patients who experienced a heart attack. 
 This study also shows that at the dose of 5 µM, catechin significantly protected the heart 
against cell death and oxidative damage. Based on a review of the literature, this study is the first 
to report the protective effect of catechin using this dose. Ascorbate and catechin have shown 
promising results in protecting the heart against oxidative damage and cell death; however there 
was no evidence of any synergistic protective effect when ascorbate and catechin were given 
together. 
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6.2. Future directions 
 In future studies, one should consider comparing the protective effect of different classes 
of flavonoids and their potency against ischemia-reperfusion injury in an isolated rat heart using 
a dose-response curve to determine the best effective dose. This will show which class of 
flavonoid is the most potent. 
 Since, there was no synergistic protective effect when ascorbate and catechin were given 
together in the current study, it is highly recommended for future studies to lower the doses of 
ascorbate and catechin, because these doses had such strong effects alone. Also they are at the 
upper limit of dietary-relevant concentrations in blood. It is possible for example that 50 µM of 
ascorbate and 1 µM or less of catechin would show a cooperative effect when combined 
together. 
  Since the effect of 150 µM ascorbate has shown less edema and degeneration compared 
to IR rat based on the histological analysis using H&E stain in a sample size of n =1, it will be 
useful to test the same dose of ascorbate using triphenyl tetrazolium chloride (TTC) stain which 
is a well-known method to detect the infarction size in ischemic myocardium, to determine if 
ascorbate can reduce the infarction size significantly or not. 
 The time of global ischemia in this study was 30 minutes.  Future studies should consider 
using 45 minutes of ischemia to cause more insult to the heart, which will help to evaluate the 
potency of using 150 µM of ascorbate following more stress on the heart. Furthermore, the time 
period between isolation of the heart and mounting the aorta should be limited to four minutes to 
avoid the damaging of the heart if the hypoxic duration is too long, and the potential effect of 
ischemic preconditioning if perfusion is delayed. 
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 The effect of ascorbate and catechin should be tested in an in vivo experiment as well to 
compare it with the ex-vivo results. It will also be useful if future studies can test the same dose 
of ascorbate and catechin in clinical situations such as angioplasty and heart transplantation if 
added directly into the perfusate during the reperfusion period.  
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